Managing Osteoporosis in Primary Care: Highlights from Osteoporosis Canada Guidelines

Papaioannou A Morin S Cheung AM 2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary. CMAJ 2010; 182: 1864–73.

Brown JP Josse RG ; Scientific Advisory Council of the Osteoporosis Society of Canada. 2002 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada. CMAJ 2002; 167 (10 Suppl): S1–34.

Cheung AM Detsky AS . Osteoporosis and fractures: missing the bridge? JAMA 2008; 299: 1468–70.

Bessette L Ste-Marie LG Jean S The care gap in diagnosis and treatment of women with a fragility fracture. Osteoporos Int 2008; 19: 79–86.

Leslie WD Berger C Langsetmo L Construction and validation of a simplified fracture risk assessment tool for Canadian women and men: results from the CaMos and Manitoba BMD cohorts. Osteoporos Int 2010 Oct 22. Epub ahead of print.

Leslie WD Lix LM Langsetmo L Construction of a FRAX® model for the assessment of fracture probability in Canada and implications for treatment. Osteoporos Int 2011; 22 (3): 817–27.

Lentle BC Brown JP Khan A Recognizing and reporting vertebral fractures: reducing the risk of future osteoporotic fractures. Can Assoc Radiol J 2007; 58: 27–36.

Lindsay R Silverman SL Cooper C Risk of new vertebral fracture in the year following a fracture. JAMA 2001; 285: 320–3.

Leslie WD Lix LM Johansson H ; Manitoba Bone Density Program. Independent clinical validation of a Canadian FRAX® tool: fracture prediction and model calibration. J Bone Miner Res 2010; 25: 2350–8.

Leslie WD Tsang JF Lix LM ; Manitoba Bone Density Program. Simplified system for absolute fracture risk assessment: clinical validation in Canadian women. J Bone Miner Res 2009; 24: 353–60.

Fraser L Langsetmo L Berger C Fracture prediction and calibration of a Canadian FRAX tool: a population-based report from CaMos. Osteoporos Int 2011; 22: 829–37.

Siminoski K Leslie WD Frame H Recommendations for bone mineral density reporting in Canada. Can Assoc Radiol J 2005; 56: 178–88.

Kanis JA Johnell O De Laet C A meta-analysis of previous fracture and subsequent fracture risk. Bone 2004; 35: 375–82.

Kanis JA Johansson H Oden A A meta-analysis of prior corticosteroid use and fracture risk. J Bone Miner Res 2004; 19: 893–9.

Papaioannou A Morin S Cheung AM Appendix 1: Background materials for 2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada. CMAJ 2010;doi 10.1503/cmaj.100771.

Hanley DA Cranney A Jones G Vitamin D in adult health and disease: a review and guideline statement from Osteoporosis Canada (summary). CMAJ 2010; 182: 1315–9.

Institute of Medicine. Dietary reference intakes for calcium, phosphorus, magnesium, vitamin D and fluoride. Washington (DC): National Academy Press; 1997.

Holick MF . Vitamin D deficiency. N Engl J Med 2007; 357: 266–81.

Freedman DM Looker AC Chang SC Prospective study of serum vitamin D and cancer mortality in the United States. J Natl Cancer Inst 2007; 99: 1594–602.

Working Group of the Australian and New Zealand Bone and Mineral Society, Endocrine Society of Australia, Osteoporosis Australia. Vitamin D and adult bone health in Australia and New Zealand: a position statement. Med J Aust 2005; 182: 281–5.

Webb AR . Who, what, where and when — influences on cutaneous vitamin D synthesis. Prog Biophys Mol Biol 2006; 92: 17–25.

Lucas R McMichael T Smith W Solar ultraviolet radiation: Global burden of disease from solar ultraviolet radiation. Geneva (Switzerland): World Health Organization; 2006.

Heaney RP Davies KM Chen TC Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol. Am J Clin Nutr 2003; 77: 204–10.

Rucker D Allan JA Fick GH Vitamin D insufficiency in a population of healthy western Canadians. CMAJ 2002; 166: 1517–24.

Vieth R Cole DE Hawker GA Wintertime vitamin D insufficiency is common in young Canadian women, and their vitamin D intake does not prevent it. Eur J Clin Nutr 2001; 55: 1091–7.

Bischoff-Ferrari HA Giovannucci E Willett WC Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr 2006; 84: 18–28.

Hathcock JN Shao A Vieth R Risk assessment for vitamin D. Am J Clin Nutr 2007; 85: 6–18.

Bischoff-Ferrari HA Dietrich T Orav EJ Higher 25-hydroxyvitamin D concentrations are associated with better lower-extremity function in both active and inactive persons aged ≥60 y. Am J Clin Nutr 2004; 80: 752–8.

Bischoff HA Stahelin HB Dick W Effects of vitamin D and calcium supplementation on falls: a randomized controlled trial. J Bone Miner Res 2003; 18: 343–51.

Jackson RD LaCroix AZ Gass M Calcium plus vitamin D supplementation and the risk of fractures. N Engl J Med 2006; 354: 669–83.

Bischoff-Ferrari HA Dietrich T Orav EJ Positive association between 25-hydroxy vitamin D levels and bone mineral density: a population-based study of younger and older adults. Am J Med 2004; 116: 634–9.

Dawson-Hughes B Heaney RP Holick MF Estimates of optimal vitamin D status. Osteoporos Int 2005; 16: 713–6.

Stone K Bauer DC Black DM Hormonal predictors of bone loss in elderly women: a prospective study. The Study of Osteoporotic Fractures Research Group. J Bone Miner Res 1998; 13: 1167–74.

Dawson-Hughes B Harris SS Krall EA Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older. N Engl J Med 1997; 337: 670–6.

Grados F Brazier M Kamel S Effects on bone mineral density of calcium and vitamin D supplementation in elderly women with vitamin D deficiency. Joint Bone Spine 2003; 70: 203–8.

Cooper L Clifton-Bligh PB Nery ML Vitamin D supplementation and bone mineral density in early postmenopausal women. Am J Clin Nutr 2003; 77: 1324–9.

Bischoff-Ferrari HA Kiel DP Dawson-Hughes B Dietary calcium and serum 25-hydroxyvitamin D status in relation to BMD among US adults. J Bone Miner Res 2009; 24: 935–42.

Bischoff-Ferrari HA Willett WC Wong JB Fracture prevention with vitamin D supplementation: a meta-analysis of randomized controlled trials. JAMA 2005; 293: 2257–64.

Bischoff-Ferrari HA Willett WC Wong JB Prevention of nonvertebral fractures with oral vitamin D and dose dependency: a meta-analysis of randomized controlled trials. Arch Intern Med 2009; 169: 551–61.

Bischoff-Ferrari HA Dawson-Hughes B Willett WC Effect of vitamin D on falls: a meta-analysis. JAMA 2004; 291: 1999–2006.

Tang BM Eslick GD Nowson C Use of calcium or calcium in combination with vitamin D supplementation to prevent fractures and bone loss in people aged 50 years and older: a meta-analysis. Lancet 2007; 370: 657–66.

Reid IR Bolland MJ Grey A . Effect of calcium supplementation on hip fractures. Osteoporos Int 2008; 19: 1119–23.

Bolland MJ Avenell A Baron JA Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: meta-analysis. BMJ 2010; 341: c3691.

Li WC Chen YC Yang RS Effects of exercise programmes on quality of life in osteoporotic and osteopenic postmenopausal women: a systematic review and meta-analysis. Clin Rehabil 2009; 23: 888–96.

Moayyeri A . The association between physical activity and osteoporotic fractures: a review of the evidence and implications for future research. Ann Epidemiol 2008; 18: 827–35.

Hip protectors in long-term care policy guidance and implementation. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health, Health Technology Inquiry Service; 2010.

MacLean C Newberry S Maglione M Systematic review: comparative effectiveness of treatments to prevent fractures in men and women with low bone density or osteoporosis. Ann Intern Med 2008; 148: 197–213.

Cranney A Guyatt G Griffith L ; Osteoporosis Methodology Group and The Osteoporosis Research Advisory Group. Meta-analyses of therapies for postmenopausal osteoporosis. IX: Summary of meta-analyses of therapies for postmenopausal osteoporosis. Endocr Rev 2002; 23: 570–8.

Bolland MJ Grey AB Gamble GD Effect of osteoporosis treatment on mortality: a meta-analysis. J Clin Endocrinol Metab 2010; 95: 1174–81.

Lyles KW Colon-Emeric CS Magaziner JS Zoledronic acid and clinical fractures and mortality after hip fracture. N Engl J Med 2007; 357: 1799–809.

Rahmani P Morin S . Prevention of osteoporosis-related fractures among postmenopausal women and older men. CMAJ 2009; 181: 815–20.

Cummings SR San Martin J McClung MR Denosumab for prevention of fractures in postmenopausal women with osteoporosis. N Engl J Med 2009; 361: 756–65.

Black DM Schwartz AV Ensrud KE Effects of continuing or stopping alendronate after 5 years of treatment: the Fracture Intervention Trial Long-term Extension (FLEX): a randomized trial. JAMA 2006; 296: 2927–38.

Watts NB Chines A Olszynski WP Fracture risk remains reduced one year after discontinuation of risedronate. Osteoporos Int 2008; 19: 365–72.

Schneider DL Barrett-Connor EL Morton DJ . Timing of postmenopausal estrogen for optimal bone mineral density. The Rancho Bernardo Study. JAMA 1997; 277: 543–7.

Greenspan SL Resnick NM Parker RA . Combination therapy with hormone replacement and alendronate for prevention of bone loss in elderly women: a randomized controlled trial. JAMA 2003; 289: 2525–33.

Johnell O Scheele WH Lu Y Additive effects of raloxifene and alendronate on bone density and biochemical markers of bone remodeling in postmenopausal women with osteoporosis. J Clin Endocrinol Metab 2002; 87: 985–92.

Van Staa TP Laan RF Barton IP Bone density threshold and other predictors of vertebral fracture in patients receiving oral glucocorticoid therapy. Arthritis Rheum 2003; 48: 3224–9.